GlassScriptPhysician profile
Adam Didyk
NPI 1629286257
$1,639.91
in general payments reported to CMS, 2019-2025
21 companies · $21.13 in 2025
The $21.13 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $239 · 2021: $299 · 2022: $95.12 · 2023: $266 · 2024: $331 · 2025: $21.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $309.61 | 2020-2024 | Variax |
| Organogenesis INC. | $190.03 | 2020-2023 | Puraply |
| Smith+Nephew, INC. | $151.32 | 2023-2024 | Grafix Pl, Grafix, Stravix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $146.29 | 2021-2025 | Jublia |
| Fusion Orthopedics USA, LLC | $134.37 | 2023 | |
| Sebela Pharmaceuticals INC. | $131.45 | 2019-2023 | Naftin, Pramosone |
| Depuy Synthes Sales INC. | $100.04 | 2019-2024 | Motoband |
| Melinta Therapeutics, LLC | $99.55 | 2019 | |
| Wright Medical Technology, INC. | $93.28 | 2019 | |
| Horizon Therapeutics Plc | $49.39 | 2019-2021 | |
| Bioventus LLC | $40.61 | 2020-2021 | |
| Zyla Life Sciences, INC. | $38.10 | 2019 | |
| Medimetriks Pharmaceuticals, INC. | $29.95 | 2022 | |
| Medtronic Vascular, INC. | $21.33 | 2019 | |
| Paratek Pharmaceuticals, INC. | $20.81 | 2024 | Nuzyra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $18.13 | 2023 | Senza |
| Ovik Health, LLC | $15.83 | 2019 | |
| Ibsa Pharma INC. | $13.84 | 2021 | |
| Assertio Therapeutics, INC. | $12.71 | 2019 | |
| Sandoz INC. | $12.27 | 2020 | |
| Glenmark Therapeutics INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Didyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.